-
Sector Analysis
NewUrea Capacity and Capital Expenditure Outlook by Region, Countries, Companies, Projects and Forecast to 2030
Urea Industry Capacity & Capital Expenditure (Capex) Overview The urea capacity was 241.92 million tonnes per annum (mtpa) in 2023. The use of urea as fertilizer in the agriculture industry and for industrial applications such as for production of plastics is driving global urea demand. Furthermore, Asia, FSU, and the Middle East will primarily drive the global Urea capacity growth during the outlook period. Urea Industry Capacity and Capex Outlook, 2024-2030 (mtpa) Buy the Full Report for More Insights into...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PT-00114 in Post-Traumatic Stress Disorder (PTSD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PT-00114 in Post-Traumatic Stress Disorder (PTSD) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PT-00114 in Post-Traumatic Stress Disorder (PTSD) Drug Details: PT-00114 (TCAP-1)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Belzutifan in Pheochromocytoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Belzutifan in Pheochromocytoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Belzutifan in Pheochromocytoma Drug Details: Belzutifan (Welireg) is an anti-cancer agent. It...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Belzutifan in Gastrointestinal Stromal Tumor (GIST)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Belzutifan in Gastrointestinal Stromal Tumor (GIST) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Belzutifan in Gastrointestinal Stromal Tumor (GIST) Drug Details: Belzutifan...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Belzutifan in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Belzutifan in Metastatic Castration-Resistant Prostate Cancer (mCRPC) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Belzutifan in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Belzutifan in Pancreatic Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Belzutifan in Pancreatic Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Belzutifan in Pancreatic Tumor Drug Details: Belzutifan (Welireg) is an anti-cancer...
-
Product Insights
NewPharmaTech Solutions Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our PharmaTech Solutions Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. PharmaTech Solutions Inc (PTS), a subsidiary of Decision Diagnostics Corp, is a manufacturer and supplier of wholesale prescription drugs, home diagnostic and treatment products. The company offers blood glucose testing products to identify diabetes; and virion screening test system for screening coronavirus. It also develops test strips to detect diabetes in cats, dogs, and horses. The company markets its...
-
Product Insights
NewQuarterly Hot Coffee pricing trends in China
Empower your strategies with our Quarterly Hot Coffee pricing trends in China report and make more profitable business decisions. Consumers’ preferences for stores are most heavily influenced by pricing and promotions, but brands and retailers continue to adjust prices and promotions based on insufficient information from expensive, drawn-out, and incomplete audits of rival techniques. Brands and retailers can benefit from the unique intelligence provided by GlobalData Ecommerce Price Tracker, covering millions of SKUs, to identify, anticipate, and implement important business...
-
Sector Analysis
Indonesia Green Buildings Market Summary, Competitive Analysis and Forecast to 2028
Green Buildings in Indonesia industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2019-23, and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Key Highlights - Green Buildings involve the design, construction, operation, and maintenance of buildings in an environmentally responsible and resource-efficient way. The goal of green buildings is to minimize a building's negative impact on the...
-
Thematic Analysis
NewAgriculture M&A Deals, Q1 2024 – Top Themes – Thematic Intelligence
This report analyzes the disruptive themes that have driven M&A activity in Q1 2024 in the Agriculture Sector.